HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Gd-EDDA/HYNIC-RGD as an MR molecular probe imaging integrin alphanubeta3 receptor-expressed tumor-MR molecular imaging of angiogenesis.

AbstractRATIONALE AND OBJECTIVE:
The aim of this study is to develop a novel MR probe containing arginine-glycine-aspartic acid (RGD) motif for imaging integrin alphanubeta3 receptor-expressed tumor.
MATERIALS AND METHODS:
Commercially available HYNIC-RGD conjugated with co-ligand EDDA was labeled with Gd(3+), and the mixture was isolated and purified by solid phase extract (SPE) to get the entire probe Gd-EDDA/HYNIC-RGD. Human hepatocellular carcinoma (HHCC) cell line BEL-7402 was cultured and the cells harvested and suspended in serum-free Dulbecco's modified Eagle medium (DMEM) were subcutaneously inoculated into athymic nude mice for tumor growth. In vitro cell binding assay to integrin alphanubeta3 receptor and cell viability experiments were conducted. The in vivo imaging of the three arms of xenografts were performed by MR scan with a dedicated animal coil at time points of 0, 30, 60, 90min and 24-h post-intravenous injection (p.i.). Three arms of nude mice then were sacrificed for histological examination to confirm the imaging results.
RESULTS:
Gd-EDDA/HYNIC-RGD was successfully isolated by SPE and validity was verified on signal enhancement through in vitro and in vivo experiments. The nude mice model bearing HHCC was well established. There was approx. 30% signal enhancement on T1WI FSE images at 90min post-intravenous injection of the Gd-EDDA/HYNIC-RGD compared with baseline, and the signal to time curve is straightforward over time in the span of 0-90min p.i., while the control arms do not show this tendency.
CONCLUSION:
Gd-EDDA/HYNIC-RGD has the potential to serve as an MR probe detecting integrin alphanubeta3 receptor-expressed tumor.
AuthorsTianlong Huo, Xiangke Du, Sen Zhang, Xia Liu, Xubing Li
JournalEuropean journal of radiology (Eur J Radiol) Vol. 73 Issue 2 Pg. 420-7 (Feb 2010) ISSN: 1872-7727 [Electronic] Ireland
PMID19261416 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
CopyrightCopyright (c) 2008 Elsevier Ireland Ltd. All rights reserved.
Chemical References
  • 6-hydrazinopyridine-3-carboxylic acid
  • Contrast Media
  • Diethylamines
  • Hydrazines
  • Integrin alphaVbeta3
  • Nicotinic Acids
  • Oligopeptides
  • arginyl-glycyl-aspartic acid
  • Gadolinium
  • 2,2'-(ethylenedioxy)diethylamine
Topics
  • Animals
  • Carcinoma, Hepatocellular (diagnosis, metabolism)
  • Cell Line, Tumor
  • Contrast Media (chemistry)
  • Diethylamines (chemistry)
  • Gadolinium (chemistry, pharmacokinetics)
  • Humans
  • Hydrazines (chemistry)
  • Image Enhancement (methods)
  • Integrin alphaVbeta3 (metabolism)
  • Magnetic Resonance Imaging (methods)
  • Mice
  • Mice, Nude
  • Molecular Probe Techniques
  • Neovascularization, Pathologic (diagnosis, metabolism)
  • Nicotinic Acids (chemistry)
  • Oligopeptides (chemistry, pharmacokinetics)
  • Rats
  • Reproducibility of Results
  • Sensitivity and Specificity

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: